Black Diamond Therapeutics (BDTX) Other Working Capital Changes (2019 - 2021)
Historic Other Working Capital Changes for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to -$3.9 million.
- Black Diamond Therapeutics' Other Working Capital Changes fell 44376.66% to -$3.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.7 million, marking a year-over-year decrease of 15015.99%. This contributed to the annual value of -$3.4 million for FY2024, which is 928.07% down from last year.
- Per Black Diamond Therapeutics' latest filing, its Other Working Capital Changes stood at -$3.9 million for Q4 2021, which was down 44376.66% from -$793000.0 recorded in Q3 2021.
- Black Diamond Therapeutics' Other Working Capital Changes' 5-year high stood at $3.8 million during Q1 2020, with a 5-year trough of -$3.9 million in Q4 2021.
- Its 3-year average for Other Working Capital Changes is $228166.7, with a median of $59500.0 in 2019.
- Examining YoY changes over the last 5 years, Black Diamond Therapeutics' Other Working Capital Changes showed a top increase of 22200.84% in 2020 and a maximum decrease of 115000.0% in 2020.
- Quarter analysis of 3 years shows Black Diamond Therapeutics' Other Working Capital Changes stood at $754000.0 in 2019, then skyrocketed by 50.0% to $1.1 million in 2020, then plummeted by 443.77% to -$3.9 million in 2021.
- Its Other Working Capital Changes stands at -$3.9 million for Q4 2021, versus -$793000.0 for Q3 2021 and $151000.0 for Q2 2021.